Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ola Hammarsten

Showing results (71-80 of 100) with videos related to

Pageof 10
Sort By:
Clinical Chemistry|February 11, 2020
A Possible Mechanism behind Faster Clearance and Higher Peak Concentrations of Cardiac Troponin I Compared with Troponin T in Acute Myocardial InfarctionKarin Starnberg, Vincent Fridén, Aida Muslimovic, et al.
Orphanet Journal of Rare Diseases|February 15, 2022
Clinical measurement of cellular DNA damage hypersensitivity in patients with DNA repair defectsOla Hammarsten, Anna Lyytikäinen, Sofia Thunström, et al.
Clinical Chemistry|December 30, 2020
Getting Cardiac Troponin Right: Appraisal of the 2020 European Society of Cardiology Guidelines for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation by the International Federation of Clinical Chemistry and Laboratory Medicine Committee on Clinical Applications of Cardiac Bio-MarkersFred S Apple, Paul O Collinson, Peter A Kavsak, et al.
Experimental Cell Research|April 26, 2016
Linking loss of sodium-iodide symporter expression to DNA damageMadeleine Nordén Lyckesvärd, Nirmal Kapoor, Camilla Ingeson-Carlsson, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|May 23, 2022
The clinical approach to diagnosing peri-procedural myocardial infarction after percutaneous coronary interventions according to the fourth universal definition of myocardial infarction - from the study group on biomarkers of the European Society of Cardiology (ESC) Association for Acute CardioVascular Care (ACVC)Johannes Mair, Allan Jaffe, Bertil Lindahl, et al.
European Journal of Cell Biology|November 9, 2020
Novel clearance of muscle proteins by muscle cellsAida Muslimovic, Vincent Fridén, Karin Starnberg, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|January 9, 2022
The ratio of cardiac troponin T to troponin I may indicate non-necrotic troponin release among COVID-19 patientsOla Hammarsten, Pontus Ljungqvist, Björn Redfors, et al.
Clinical Chemistry|June 18, 2022
Analytical Considerations in Deriving 99th Percentile Upper Reference Limits for High-Sensitivity Cardiac Troponin Assays: Educational Recommendations from the IFCC Committee on Clinical Application of Cardiac Bio-MarkersKristin M Aakre, Amy K Saenger, Rick Body, et al.
Transplantation|July 14, 2022
Long-term Transplant Function After Thrombolytic Treatment Ex Vivo of Donated Kidneys Retrieved 4 to 5 H After Circulatory DeathMichael Olausson, Deepti Antony, Martin Johansson, et al.
European Heart Journal. Acute Cardiovascular Care|March 3, 2021
Cardiovascular biomarkers in patients with COVID-19Christian Mueller, Evangelos Giannitsis, Allan S Jaffe, et al.
Pageof 10

Showing results (71-80 of 100) with videos related to

Sort By:
Pageof 10
Clinical Chemistry|February 11, 2020
A Possible Mechanism behind Faster Clearance and Higher Peak Concentrations of Cardiac Troponin I Compared with Troponin T in Acute Myocardial InfarctionKarin Starnberg, Vincent Fridén, Aida Muslimovic, et al.
Orphanet Journal of Rare Diseases|February 15, 2022
Clinical measurement of cellular DNA damage hypersensitivity in patients with DNA repair defectsOla Hammarsten, Anna Lyytikäinen, Sofia Thunström, et al.
Clinical Chemistry|December 30, 2020
Getting Cardiac Troponin Right: Appraisal of the 2020 European Society of Cardiology Guidelines for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation by the International Federation of Clinical Chemistry and Laboratory Medicine Committee on Clinical Applications of Cardiac Bio-MarkersFred S Apple, Paul O Collinson, Peter A Kavsak, et al.
Experimental Cell Research|April 26, 2016
Linking loss of sodium-iodide symporter expression to DNA damageMadeleine Nordén Lyckesvärd, Nirmal Kapoor, Camilla Ingeson-Carlsson, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|May 23, 2022
The clinical approach to diagnosing peri-procedural myocardial infarction after percutaneous coronary interventions according to the fourth universal definition of myocardial infarction - from the study group on biomarkers of the European Society of Cardiology (ESC) Association for Acute CardioVascular Care (ACVC)Johannes Mair, Allan Jaffe, Bertil Lindahl, et al.
European Journal of Cell Biology|November 9, 2020
Novel clearance of muscle proteins by muscle cellsAida Muslimovic, Vincent Fridén, Karin Starnberg, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|January 9, 2022
The ratio of cardiac troponin T to troponin I may indicate non-necrotic troponin release among COVID-19 patientsOla Hammarsten, Pontus Ljungqvist, Björn Redfors, et al.
Clinical Chemistry|June 18, 2022
Analytical Considerations in Deriving 99th Percentile Upper Reference Limits for High-Sensitivity Cardiac Troponin Assays: Educational Recommendations from the IFCC Committee on Clinical Application of Cardiac Bio-MarkersKristin M Aakre, Amy K Saenger, Rick Body, et al.
Transplantation|July 14, 2022
Long-term Transplant Function After Thrombolytic Treatment Ex Vivo of Donated Kidneys Retrieved 4 to 5 H After Circulatory DeathMichael Olausson, Deepti Antony, Martin Johansson, et al.
European Heart Journal. Acute Cardiovascular Care|March 3, 2021
Cardiovascular biomarkers in patients with COVID-19Christian Mueller, Evangelos Giannitsis, Allan S Jaffe, et al.
Pageof 10